THE WAY OF PATHOGENETIC THERAPY IN PATIENTS SUFFERING FROM ATOPIC DERMATITIS

The condition of immune and hemostasis systems was examined in patients suffering from atopic dermatitis. 66 patients had changes in cellular and humoral components of immune system, factors of a nonspecific resistance of an organism, and also, parameters of hemostasis system testifying to a tendency to hypercoagulation. The drugs protephlazid and trental which have rendered promoted immunomodulating and hypocoagulating action were used for correction of revealed changes in patients suffering from atopic dermatitis.